Arch Therapeutics Inc (OTCQB:ARTH)

0.2825
Delayed Data
As of Apr 20
 -0.013 / -4.40%
Today’s Change
0.25
Today|||52-Week Range
0.89
-34.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization322.000.000.001.5K
 
 
 
 
Operating ExpensesGross Income-322.000.000.00-1.5K
 
 
 
General Expenses4.6M5.5M6.1M7.3M
 
 
 
 
 
Research And Development1.5M1.8M1.7M2.1M
 
 
 
 
 
Total Operating Expenses4.6M5.5M6.1M7.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.6M-5.5M-6.1M-7.3M
 
 
 
 
 
Extraordinary Credit--2.9M335.1K0.00
 
 
 
Extraordinary Charge-3.4M0.000.00-433.9K
 
 
 
Interest Expense On Debt111.1K377.8K276.7K52.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.1M-2.9M-6.0M-7.8M
 
 
 
 
 
Net Income-8.1M-2.9M-6.0M-7.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS67.5M81.4M121.5M142.7M
 
 
 
 
 
Shares To Calculate EPS Diluted67.5M81.4M121.5M142.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.04-$0.05-$0.05
 
 
 
 
 
EPS Diluted-$0.12-$0.04-$0.05-$0.05